CAN Center for Automation in Nanobiotech

Key development areas: Biosensor, nanobioelectronics and nanorobotics for in vivo nanomedicine application in diabetes, cancer, cardiology, and brain aneurysm.

CAN Center for Automation in Nanobiotech is a biotechnology company, focused on nanotechnologies for innovative integrated system implementation. The equipment prototyping at CAN should enable new treatments through in vivo diagnosis, drug delivery and surgery. Our business project is to provide new effective medical devices and therapeutic products for the development of commercial nanobiotechnology.